19-57231759-A-ACAGCCCAG
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The ENST00000302804.12(AURKC):c.94_101dup(p.Met35AlafsTer40) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000236 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00024 ( 0 hom. )
Consequence
AURKC
ENST00000302804.12 frameshift
ENST00000302804.12 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.176
Genes affected
AURKC (HGNC:11391): (aurora kinase C) This gene encodes a member of the Aurora subfamily of serine/threonine protein kinases. The encoded protein is a chromosomal passenger protein that forms complexes with Aurora-B and inner centromere proteins and may play a role in organizing microtubules in relation to centrosome/spindle function during mitosis. This gene is overexpressed in several cancer cell lines, suggesting an involvement in oncogenic signal transduction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-57231759-A-ACAGCCCAG is Pathogenic according to our data. Variant chr19-57231759-A-ACAGCCCAG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 632323.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AURKC | NM_001015878.2 | c.94_101dup | p.Met35AlafsTer40 | frameshift_variant | 2/7 | ENST00000302804.12 | NP_001015878.1 | |
AURKC | NM_001015879.2 | c.37_44dup | p.Met16AlafsTer40 | frameshift_variant | 2/7 | NP_001015879.1 | ||
AURKC | XM_047439253.1 | c.94_101dup | p.Met35AlafsTer40 | frameshift_variant | 2/5 | XP_047295209.1 | ||
AURKC | NM_003160.3 | c.-9_-2dup | 5_prime_UTR_variant | 2/7 | NP_003151.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AURKC | ENST00000302804.12 | c.94_101dup | p.Met35AlafsTer40 | frameshift_variant | 2/7 | 1 | NM_001015878.2 | ENSP00000302898 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151432Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
23
AN:
151432
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000204 AC: 51AN: 250472Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135450
GnomAD3 exomes
AF:
AC:
51
AN:
250472
Hom.:
AF XY:
AC XY:
25
AN XY:
135450
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000244 AC: 357AN: 1461890Hom.: 0 Cov.: 35 AF XY: 0.000249 AC XY: 181AN XY: 727248
GnomAD4 exome
AF:
AC:
357
AN:
1461890
Hom.:
Cov.:
35
AF XY:
AC XY:
181
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000152 AC: 23AN: 151432Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 73888
GnomAD4 genome
AF:
AC:
23
AN:
151432
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
73888
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2017 | This sequence change creates a premature translational stop signal (p.Met35Alafs*40) in the AURKC gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs757923465, ExAC 0.02%). This variant has not been reported in the literature in individuals with AURKC-related disease. Loss-of-function variants in AURKC are known to be pathogenic (PMID: 17435757, 19147683, 22888167). For these reasons, this variant has been classified as Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 09, 2018 | The p.Met35AlafsX40 variant in AURKC has not been previously reported in individ uals with spermatogenic failure, but has been identified in 0.1% (11/10368) of A shkenazi Jewish chromosomes by gnomAD (http://gnomad.broadinstitute.org). This v ariant is predicted to cause a frameshift in some (e.g. NM_001015878.1 and NM_00 1015879.1) but not all of the transcripts produced by the gene. It occurs upstre am of the start codon of an alternate transcript (NM_003160.2) and the two known pathogenic loss of function variants in this gene (p.Tyr248X and p.Leu49TrpfsX2 3) occur downstream of the start codon in all 3 transcripts. Loss of AURKC funct ion is an established disease mechanism in individuals with spermatogenic failur e (Dieterich 2007, Ben Khelifa 2011, Ben Khelifa 2012); however, given uncertain ty around which transcripts are biologically relevant, the p.Met35AlafsX40 varia nt is uncertain. ACMG/AMP Criteria applied: None. - |
Infertility associated with multi-tailed spermatozoa and excessive DNA Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 14, 2017 | The AURKC c.94_101dupAGCCCAGC (p.Met35AlafsTer40) variant results in a frameshift, and is predicted to result in premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. Based on the variant frequency, disease prevalence, disease penetrance, and inheritance mode, this variant could not be ruled out of causing disease. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for spermatogenic failure. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at